Primary Biliary Cirrhosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Clinical Trials

Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Condition:   Primary Biliary CirrhosisInterventions:   Biological: NGM282;   Biological: PlaceboSponsors:   NGM Biopharmaceuticals, Inc;   NGM Biopharmaceuticals Australia Pty LtdRecruiting - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 30, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   Lumena Pharmaceuticals, Inc.Recruiting - verified August 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   Lumena Pharmaceuticals, Inc.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   ShireCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   Lumena Pharmaceuticals, Inc.Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials

Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
Conditions:   Primary Biliary Cirrhosis;   PBCInterventions:   Drug: LUM001;   Drug: Placebo;   Drug: Ursodeoxycholic AcidSponsor:   ShireCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 17, 2013 Category: Research Source Type: clinical trials